Explore
More

Our Team

Our team of world-class scientists, builders and operators use their deep industry expertise to power the creation of life-transforming cell and gene therapies.

// About ElevateBio

Meet Our Team of Industry Experts

David Hallal

Chief Executive Officer & Chairman

Mitchell H. Finer, Ph.D.

Strategic Advisor

Vikas Sinha, MBA

Chief Financial Officer

Jacob Abrams

General Counsel

Bhakti Bhargava, MBA

SVP, Head of Finance & Accounting

Catherine Hu

SVP, Corporate Affairs & Investor Relations

Katie Jorgensen

VP, Site Head, BaseCamp

Tess Kitchener

VP, BaseCamp BD Manufacturing

Missy Kotchey

SVP, Head of People & Culture

Aaron Nudelman, Ph.D., J.D.

SVP, Head of Intellectual Property

Michael Paglia, M.S.

Chief Technology Officer of BaseCamp

Amy Pooler, Ph.D.

SVP, Research and Development of Life Edit

Heidi Wagner, J.D.

Global Head of Government Affairs

Board of Directors

We are advised and supported by a team of world-class technology and biotechnology industry experts with unmatched track records in building iconic companies and creating value in the field of rare disease and cell and gene therapy.

David Hallal

Co-Founder Chief Executive Officer & Chairman, ElevateBio

Vikas Sinha

Chief Financial Officer, ElevateBio

Ansbert Gadicke

Co-founder of MPM Capital

Morana Jovan-Embiricos, Ph.D.

Managing Partner of F2 Ventures

Germano Giuliani

Former CEO, Giuliani Pharma; Board of Directors, HBM Healthcare AH; Investment Committee Royalty Pharma

Khalil Barrage

Managing Director of The Invus Group

Karan Takhar

Managing Director, Matrix Capital Management Company

Navneet Govil

Managing Partner, SoftBank

Investors

Committed to enabling innovative cell and gene therapy companies